RAD54L2
Basic information
Region (hg38): 3:51538719-51668667
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RAD54L2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 66 | 71 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 66 | 5 | 5 |
Variants in RAD54L2
This is a list of pathogenic ClinVar variants found in the RAD54L2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-51590511-G-A | not specified | Uncertain significance (Jan 17, 2024) | ||
3-51627615-C-T | not specified | Uncertain significance (Jun 23, 2021) | ||
3-51627667-T-C | not specified | Uncertain significance (Jun 13, 2023) | ||
3-51627673-G-A | not specified | Likely benign (Aug 20, 2023) | ||
3-51627761-T-C | Benign (Mar 02, 2018) | |||
3-51629344-C-T | not specified | Uncertain significance (Jun 29, 2023) | ||
3-51629347-G-C | not specified | Uncertain significance (Jun 28, 2023) | ||
3-51629437-G-A | not specified | Uncertain significance (Sep 20, 2023) | ||
3-51630337-A-G | not specified | Uncertain significance (May 09, 2023) | ||
3-51630746-A-G | not specified | Uncertain significance (Oct 06, 2021) | ||
3-51630831-G-A | not specified | Uncertain significance (Dec 17, 2021) | ||
3-51633577-A-G | not specified | Uncertain significance (Mar 19, 2024) | ||
3-51633588-C-G | not specified | Uncertain significance (Aug 21, 2023) | ||
3-51633951-C-T | not specified | Uncertain significance (Feb 06, 2024) | ||
3-51633966-C-T | not specified | Uncertain significance (Oct 30, 2023) | ||
3-51633971-G-A | not specified | Uncertain significance (Apr 13, 2022) | ||
3-51633976-C-G | not specified | Uncertain significance (Jan 18, 2023) | ||
3-51634017-T-C | not specified | Uncertain significance (Dec 22, 2023) | ||
3-51635595-C-T | not specified | Uncertain significance (Nov 21, 2023) | ||
3-51635597-A-G | not specified | Uncertain significance (Jul 19, 2023) | ||
3-51635667-T-G | not specified | Uncertain significance (Feb 15, 2023) | ||
3-51637240-C-G | Benign (Mar 02, 2018) | |||
3-51637275-G-A | not specified | Uncertain significance (Apr 15, 2024) | ||
3-51637370-C-T | not specified | Uncertain significance (Jan 26, 2022) | ||
3-51637371-G-A | not specified | Uncertain significance (Apr 06, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RAD54L2 | protein_coding | protein_coding | ENST00000409535 | 21 | 127524 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 6.81e-10 | 125581 | 0 | 3 | 125584 | 0.0000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.13 | 592 | 849 | 0.698 | 0.0000506 | 9554 |
Missense in Polyphen | 119 | 288.67 | 0.41224 | 3201 | ||
Synonymous | 2.06 | 283 | 331 | 0.856 | 0.0000193 | 2975 |
Loss of Function | 7.20 | 1 | 62.4 | 0.0160 | 0.00000350 | 715 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000892 | 0.00000881 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000349 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: DNA helicase that modulates androgen receptor (AR)- dependent transactivation in a promoter-dependent manner. Not able to remodel mononucleosomes in vitro (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.0931
Intolerance Scores
- loftool
- rvis_EVS
- -1.39
- rvis_percentile_EVS
- 4.31
Haploinsufficiency Scores
- pHI
- 0.999
- hipred
- Y
- hipred_score
- 0.786
- ghis
- 0.578
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.758
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rad54l2
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; cellular phenotype;
Gene ontology
- Biological process
- Cellular component
- nucleus
- Molecular function
- DNA binding;helicase activity;protein binding;ATP binding